RT Book, Section
A1 Unruh, Mark
A1 Budhwar, Nitin
A2 Halter, Jeffrey B.
A2 Ouslander, Joseph G.
A2 Studenski, Stephanie
A2 High, Kevin P.
A2 Asthana, Sanjay
A2 Supiano, Mark A.
A2 Ritchie, Christine S.
A2 Schmader, Kenneth
SR Print(0)
ID 1190911845
T1 Kidney Diseases
T2 Hazzard's Geriatric Medicine and Gerontology, 8e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260464450
LK accessmedicine.mhmedical.com/content.aspx?aid=1190911845
RD 2024/09/12
AB Learning  ObjectivesRecognize  that  chronic  kidney  disease  (CKD)  is  most  often  caused  by  common  systemic  diseases,  including  diabetes  and  hypertension.Understand  that  diabetic  nephropathy  is  a  chronic  progressive  kidney  disease  that  requires  treatment  with  angiotensin-converting  enzyme  inhibitor  (ACEI)  or  angiotensin  receptor  blockers  (ARBs)  if  tolerated,  optimization  of  blood  pressure  and  blood  glucose  levels,  and  management  of  comorbidities.  SGLT2  inhibitors  and  GLP-1  receptor  agonists  show  benefits  in  treatment  of  diabetes  and  substantial  reduction  of  risk  of  kidney  disease  progression.Assess  acute  kidney  injury  (AKI)  for  pre-,  post-,  and  intrarenal  causes  among  the  older  adult.  Even  episodes  of  mild  AKI  can  increase  the  risk  for  future  CKD  and  the  etiology  of  AKI  is  often  related  to  the  sex,  age,  and  location  of  the  patient.Understand  the  prognosis  of  older  adults  with  kidney  failure.Characterize  the  approaches  to  managing  end-stage  kidney  disease  (ESKD)  among  older  adults.Describe  the  influence  of  multiple  chronic  health  conditions  on  quality  of  life  and  functioning  among  older  adults  with  kidney  failure.Recognize  the  challenges  in  providing  care  to  older  patients  with  kidney  failure  and  concurrent  cognitive  impairment  and  frailty.Discuss  the  role  of  clinicians  and  care  teams  in  advance  care  planning  for  patients  with  ESKD.